You are viewing: China Structural Heart Devices Market analysis

The China Structural Heart Devices Market was valued at $541.6 Million in 2024 and projected to reach to $929.7 Million by 2029, representing a compound annual growth rate of 11.4%. China's structural heart devices market is positioned for sustained high-growth expansion through 2029, supported by demographic shifts, rising cardiovascular disease prevalence, and healthcare modernization initiatives.

China Structural Heart Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Structural Heart Devices Market Trends and Insights

  • This growth trajectory reflects China's aging population, rising prevalence of cardiovascular diseases, and increasing healthcare investment in advanced cardiac interventions.
  • China is rapidly adopting minimally invasive structural heart procedures, driven by improved reimbursement policies and expanding access to specialized cardiac centers across urban and emerging markets. The 11.4% compound annual growth rate in China significantly outpaces the global average of 9.5%, underscoring the country's strategic importance in the structural heart devices sector.
  • China's market expansion is fueled by growing patient awareness, technological innovation in transcatheter solutions, and government initiatives to modernize cardiac care infrastructure.
  • Between 2024 and 2029, China is expected to consolidate its position as a key growth engine within the Asia Pacific region, attracting both multinational device manufacturers and domestic innovators seeking to capture market share in this high-potential geography..

Key Market Statistics

  • CAGR (2024-2029) 11.4% CAGR
  • Market Size, 2024 ~USD 541.6 Million
  • Forecast, 2029 ~USD 929.7 Million
  • Country China

China Structural Heart Devices Market Overview

Rapid Market Expansion :

China's structural heart devices market is growing at 11.4% CAGR, significantly outpacing the global rate of 9.5%, driven by increased adoption of minimally invasive cardiac procedures and government healthcare reforms.

Aging Population Dynamics :

China's rapidly aging demographic is driving demand for structural heart interventions, with cardiovascular diseases becoming a leading cause of mortality, creating sustained market opportunities through 2029.

Healthcare Investment Surge :

Substantial government investment in advanced cardiac infrastructure and reimbursement policy improvements are accelerating adoption of transcatheter aortic valve replacement (TAVR) and other structural heart procedures across Chinese hospitals.

Market Valuation Growth :

The market is projected to grow from $541.6 million in 2024 to $929.7 million by 2029, representing a 71.6% increase in market value over the five-year forecast period.

China Structural Heart Devices Market Dynamics

  • The government's commitment to expanding access to advanced cardiac interventions in both urban and emerging markets is creating significant opportunities for device manufacturers and healthcare providers.
  • Increasing physician training in minimally invasive techniques and growing patient awareness of structural heart treatment options are accelerating procedure adoption rates across major metropolitan centers and secondary cities. Competitive dynamics in China are intensifying as both multinational and domestic manufacturers expand their portfolios to meet local demand.
  • Regulatory streamlining and faster approval pathways for innovative devices are encouraging market entry and product launches.
  • Strategic partnerships between international companies and Chinese healthcare institutions are facilitating technology transfer and localized manufacturing, further supporting market penetration and accessibility across diverse patient populations..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • China's structural heart devices market will grow from $541.6M (2024) to $929.7M (2029) at an 11.4% CAGR, outpacing global growth.
    • China's aging demographic and rising cardiovascular disease burden are primary drivers of structural heart device adoption through 2029.
    • Improved reimbursement policies and expanding cardiac center infrastructure in China are accelerating minimally invasive procedure uptake.
    • China represents a critical growth engine for the Asia Pacific region, attracting multinational and domestic device manufacturers.

    Structural Heart Devices Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment TAVR/TAVI PROCEDURES (Type)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.5% from 2024 to 2029
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 16.32 (2024)
    Revenue Forecast (Billions) ~USD 25.69 (2029)
    Segments Covered Procedure, Type, Product, End User, Accessories

    China Structural Heart Devices Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Procedure

    • Repair Procedures
    • Replacement Procedures

    By Type

    • Annuloplasty
    • Biological Valves
    • Catheters
    • Closure Procedures
    • Guidewires
    • Mechanical Valves
    • Other Accessories
    • Savr Procedures
    • Sheaths
    • Surgical Heart Valves
    • Surgical Valves
    • Tavr/Tavi Procedures
    • Teer Procedures
    • Tmvr Procedures
    • Transcatheter Aortic Valve Replacement (Tavr)
    • Transcatheter Heart Valves
    • Transcatheter Mitral Valve Replacement (Tmvr)
    • Valvuloplasty

    By Product

    • Accessories
    • Annuloplasty Rings
    • Heart Valve Devices
    • Occluders, Closure Systems And Delivery Systems
    • Occluders, Closure Systems, And Delivery Systems

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Hospitals
    • Other Accessories
    • Other End Users
    • Other End Users (Cath Labs, Cardiac Centers )
    • Other End Users (Cath Labs, Cardiac Centers)
    • Other End Users (Cath Labs, Cardiac Centres)
    • Others End Users

    By Accessories

    • Catheters
    • Guidewires
    • Other Accessories
    • Sheaths

    CHINA: STRUCTURAL HEART DEVICES MARKET, BY END USER,2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    AMBULATORY SURGICAL CENTERS92.4101.6111.4122.3134.3147.5162.3178.79.9
    HOSPITALS667738.5815.1900.4994.91100.51218.51350.310.6
    OTHER END USERS (CATH LABS, CARDIAC CENTERS)86.496.5107.5119.9133.7149.3166.8186.511.6
    TOTAL845.7936.71034.11142.71262.81397.31547.61715.510.7

    Target Audience

    • Medical Device Manufacturers : Strategic planning for market entry, product localization, and competitive positioning in China's high-growth structural heart devices segment with detailed market sizing and growth forecasts.
    • Healthcare Investors & PE Firms : Investment thesis development and portfolio company strategy for cardiac device companies targeting China, with market valuation data and growth trajectory analysis through 2029.
    • Hospital & Healthcare Systems : Procurement and capital budgeting decisions for structural heart device programs, supported by market trends, clinical adoption patterns, and reimbursement environment analysis specific to China.
    • Regulatory & Market Access Consultants : Guidance on China's regulatory pathways, approval timelines, and market access strategies for structural heart devices, informed by current market dynamics and policy landscape.
    • Research & Analytics Professionals : Comprehensive market data and forecasts for China's structural heart devices sector, enabling competitive intelligence, market analysis, and strategic recommendations for stakeholders.

    Reasons to Buy this Report

    • Market-Specific Growth Intelligence : Gain detailed insights into China's 11.4% CAGR trajectory, significantly outpacing global growth, enabling strategic market entry and expansion planning tailored to this high-growth region.
    • Demographic & Clinical Opportunity Analysis : Understand China's aging population dynamics and rising cardiovascular disease burden, identifying specific patient segments and clinical needs driving structural heart device demand.
    • Regulatory & Reimbursement Landscape : Access comprehensive analysis of China's healthcare policy environment, government investment initiatives, and reimbursement frameworks shaping market accessibility and pricing strategies.
    • Competitive Positioning Data : Benchmark against multinational and domestic competitors operating in China's market, with insights on market share dynamics, partnership strategies, and localization approaches.
    • Five-Year Forecast & Investment Planning : Leverage detailed projections showing market growth from $541.6M to $929.7M by 2029, supporting capital allocation decisions, R&D prioritization, and commercial expansion timelines.

    Frequently asked questions

    What is the current market size of structural heart devices in China?

    China's structural heart devices market was valued at $541.6 million in 2024 and is projected to reach $929.7 million by 2029.

    What is the expected growth rate for structural heart devices in China?

    China's structural heart devices market is expected to grow at a compound annual growth rate (CAGR) of 11.4% from 2024 to 2029.

    Why is China's structural heart devices market growing faster than the global average?

    China's 11.4% CAGR exceeds the global 9.5% rate due to an aging population, rising cardiovascular disease prevalence, improved reimbursement policies, and expanding cardiac care infrastructure.

    What factors are driving structural heart device adoption in China?

    Key drivers include China's demographic shift toward an older population, increased healthcare investment, government modernization initiatives, growing patient awareness, and technological advances in transcatheter solutions.

    How does China's market compare to other Asia Pacific countries?

    China is the largest and fastest-growing structural heart devices market in Asia Pacific, serving as a critical growth engine for the region and attracting significant investment from multinational and domestic manufacturers.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

    The following is a breakdown of the primary respondents:

    Structural Heart Devices Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue.

    As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the Structural heart devices market includes the following details.

    The market sizing of the market was undertaken from the global side.

    Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

    Structural Heart Devices Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

    Market Definition

    Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

    Stakeholders

    • Medical Device Manufacturers
    • Cardiologists
    • Interventional Cardiologist
    • Healthcare institutions (hospitals and outpatient clinics)
    • Distributors and suppliers
    • Research institutes
    • Health insurance payers
    • Market research and consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Get the Full Structural Heart Devices Market Report

    Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status